PMC:7601109 / 761-997 JSONTXT

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T81360","span":{"begin":64,"end":65},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T83052","span":{"begin":200,"end":201},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T91336","span":{"begin":214,"end":217},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, and exercise mimetics) are being explored in different stages of trials, not a single drug has been approved for "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":209,"end":213},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, and exercise mimetics) are being explored in different stages of trials, not a single drug has been approved for "}

{"project":"LitCovid-PubTator","denotations":[{"id":"34","span":{"begin":100,"end":110},"obj":"Chemical"}],"attributes":[{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"MESH:C000596367"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"hospitalization, disability, and institutionalization. Although a few pharmacological agents (e.g., bimagrumab, sarconeos, and exercise mimetics) are being explored in different stages of trials, not a single drug has been approved for "}